Importance of medical technologies and digital tools
The rapid development and deployment of medical technologies and digital tools, including AI analytics are vital to improve surveillance and care for epidemics.
The following is an overview of how the EU is supporting the development of these technologies.
2nd Horizon 2020 call for expression of interest (August 2020)
In May 2020, the Commission launched a second emergency call, through which €128.2 million were awarded to 23 projects. In March 2021, a 24th project was added from the reserve list, bringing total funding to €133.4 million. The 24 research projects involve 354 teams from 39 countries across Europe and beyond.
Among these, 13 projects will receive a total of €55.1 million to develop Medical technologies, Digital tools and Artificial Intelligence analytics to improve surveillance and care at high Technology Readiness Levels:
Empathic platform to personally monitor, Stimulate, enrich, and aSsist Elders aNd Children in their Environment. Led by Politecnico di Milano (IT).
Telehealth-ready AI-powered multi-parametric system for surveillance of COVID-19 and cardio-pulmonary chronic patients. Led by Bat-Call Ltd (IL).
AI-based chest CT analysis enabling rapid COVID diagnosis and prognosis led by Icometrix NV (BE).
Portable platform for the assessment of microvascular health in covid-19 patients at the intensive care. Led by Institut de Ciències Fotòniques - ICFO (ES).
Controlling viral aerosols in COVID-19 and beyond. Led by Palliare Ltd (IE).
Lab to Fab development of air decontamination system for protecting health practitioners against COVID19. Led by Villinger GmbH (AT).
Cyber-Physical Intensive Care Medical System for Covid-19. Led by UNINOVA-Instituto de Desenvolvimento de Novas Tecnologias (PT).
Intelligent plug-and-play digital tool for real-time surveillance of COVID-19 patients and smart decision making in Intensive Care Units. Led by Johann Wolfgang Goethe-Universität Frankfurt am Main (DE)
COVID eXponential Programme. Led by F6S Network Ltd (IE)
Boosting Innovation for COVID-19 Diagnostic, Prevention and Surveillance. Led by Laboratório Ibérico Internacional de Nanotecnologia - INL (PT).
Market Release of a Portable Device for COVID-19 at the Point-of-Care; a Global Diagnostics Approach. Led by Idryma Technologias Kai Erevnas (EL).
A diagnostic test to improve surveillance and care of COVID-19 patients. Led by Luxembourg Institute of Health (LU).
Portable and fast surface plasmon resonance point-of-care test for COVID-19. Led by Université de Lille (FR).